175 related articles for article (PubMed ID: 37238150)
21. Salivary Exosome and Cell-Free DNA for Cancer Detection.
Hyun KA; Gwak H; Lee J; Kwak B; Jung HI
Micromachines (Basel); 2018 Jul; 9(7):. PubMed ID: 30424273
[TBL] [Abstract][Full Text] [Related]
22. Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.
Werner B; Warton K; Ford CE
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267615
[TBL] [Abstract][Full Text] [Related]
23. Preanalytical variables that affect the outcome of cell-free DNA measurements.
Ungerer V; Bronkhorst AJ; Holdenrieder S
Crit Rev Clin Lab Sci; 2020 Nov; 57(7):484-507. PubMed ID: 32393081
[TBL] [Abstract][Full Text] [Related]
24. Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients.
Huang RSP; Xiao J; Pavlick DC; Guo C; Yang L; Jin DX; Fendler B; Severson E; Killian JK; Hiemenz M; Duncan D; Lin DI; Dennis L; Aiyer A; Gjoerup O; Oxnard G; Venstrom J; Elvin J; Ramkissoon SH; Ross JS
Clin Chem; 2021 Nov; 67(11):1554-1566. PubMed ID: 34626187
[TBL] [Abstract][Full Text] [Related]
25. Methods for the Detection of Circulating Biomarkers in Cancer Patients.
Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM
Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
[No Abstract] [Full Text] [Related]
27. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
[TBL] [Abstract][Full Text] [Related]
28. Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.
Shi J; Zhang R; Li J; Zhang R
Theranostics; 2020; 10(11):4737-4748. PubMed ID: 32308746
[TBL] [Abstract][Full Text] [Related]
29. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
30. Clinical Practice Guidelines for Pre-Analytical Procedures of Plasma Epidermal Growth Factor Receptor Variant Testing.
Shin S; Woo HI; Kim JW; M D YK; Lee KA
Ann Lab Med; 2022 Mar; 42(2):141-149. PubMed ID: 34635607
[TBL] [Abstract][Full Text] [Related]
31. [Genomic Analysis and Immunotherapy by Liquid Biopsy].
Iinuma H
Gan To Kagaku Ryoho; 2019 Sep; 46(9):1361-1366. PubMed ID: 31530771
[TBL] [Abstract][Full Text] [Related]
32. A nano-magnetic size selective cfDNA extraction platform for liquid biopsy with enhanced precision.
Liu Y; Cheng L; Wang G; Lv J; He Y; Shao PL; Hu R; Xiao H; Tang J; Niu D; Yang J; Tang Z; Xu Z; Liu Y; Li Y; Song K; Wu B; Zhang B
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1199():123236. PubMed ID: 35472714
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
34. Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer.
Birknerova N; Mancikova V; Paul ED; Matyasovsky J; Cekan P; Palicka V; Parova H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230805
[TBL] [Abstract][Full Text] [Related]
35. The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.
Peng H; Pan M; Zhou Z; Chen C; Xing X; Cheng S; Zhang S; Zheng H; Qian K
Front Cell Dev Biol; 2024; 12():1385041. PubMed ID: 38784382
[TBL] [Abstract][Full Text] [Related]
36. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome.
Van Paemel R; De Koker A; Caggiano C; Morlion A; Mestdagh P; De Wilde B; Vandesompele J; De Preter K
Epigenetics; 2021; 16(7):797-807. PubMed ID: 33074045
[TBL] [Abstract][Full Text] [Related]
38. Cell-Free DNA: Applications in Different Diseases.
Ranucci R
Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
40. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
